SEC Form D · filed July 25, 2017
VenatoRx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Steven Frankel · New York, NYDirectorGregg Johnson · Santa Barbara, CAExecBrett Queener · Santa Barbara, CADirectorAlain I. Karaoglan · New York, NYDirectorLuigi J. Xerri · Malvern, PAExecMark Suster · Santa Barbara, CAExec · DirectorRobert F. Friel · New York, NYExecJoseph Lonsdale · San Francisco, CADirectorWilliam O'Halloran · Boston, MAExec · DirectorJohn M. Yanchek · Boston, MADirectorNicholas A. Sinatra · Buffalo, NYExecAnthony R. Nanula · Buffalo, NYDirectorPatrick Finucane · Buffalo, NYDirectorAndrew S. Zimmerman · Austin, TXExecTrevor S. Dallas · Austin, TXDirectorAdam Fuller · Atlanta, GAExecAnthony J. Meehan · Malvern, PAExecTim J. Henkel · Malvern, PAExecJames J. Murphy · Malvern, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗